What is REPL stock price today?

Visit our real-time dashboard for the current REPL stock price and live market data.

Is REPL stock going up or down today?

REPL stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy REPL stock now?

The decision to buy REPL depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is REPL a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for REPL based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is REPL stock overvalued or undervalued?

Use our DCF valuation calculator to determine if REPL is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is REPL's P/E ratio?

P/E ratio data for REPL will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is REPL's market cap?

REPL (Replimune Group Inc) has a market capitalization of $0.83 billion, making it a small-cap stock.

What is REPL's price to book ratio?

REPL trades at a price-to-book (P/B) ratio of 3.44, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does REPL pay dividends?

REPL does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is REPL's dividend yield?

REPL does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is REPL stock a good long-term investment?

REPL's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is REPL's revenue growth rate?

Revenue growth data for REPL is available on our dashboard with detailed financial statement analysis.

Profitability metrics for REPL are available on our dashboard with complete income statement analysis.

What are the risks of investing in REPL?

Key risks for REPL include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does REPL compare to its competitors?

Compare REPL to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize REPL's performance and positioning.

What is REPL's stock price target for 2026?

Visit our prediction page for AI-powered price targets for REPL with bull, base, and bear case scenarios.

What do analysts say about REPL?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for REPL. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is REPL's next earnings report?

REPL reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

REPL - Replimune Group Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Replimune Group Inc

Replimune Group Inc (REPL) common stock

Price Chart

Loading chart...

REPL Key Statistics

Market Cap

$825.73M

P/B Ratio

3.44

How REPL Compares to Peers

REPL is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
REPL(This stock)	$825.73M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: June 25, 2026 at 4:16 AM EDT

Ready to invest in REPL?

Commission-free trading available. Affiliate links.

REPL Lician Score

5% confidence

4.0/10

Neutral

REPL has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates REPLacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

REPL Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for REPL

Dashboard

Enter a ticker to analyze